Alexander L. Greninger, MD, PhD

Assistant Professor
University of Washington

Disclosure(s): Abbott: Contract Testing; Cepheid: Contract Testing; Gilead: Contract Testing, Grant/Research Support; Hologic: Contract Testing; Merck: Grant/Research Support; Novavax: Contract Testing; Pfizer: Contract Testing

Poster(s):

• 307 - Diagnostic Test Kinetics, Infectivity, and Immunological Responses Among Unvaccinated Adults During Acute SARS-CoV-2 Infection
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 631 - CMV Reactivation in Hematopoietic Cell Transplant Candidates: A Novel Risk Factor for Post-transplant Reactivation
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1149 - Resistance Analyses of Patient Viral Samples from the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1)
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET

• 1948 - Evaluation of a heterologous booster vaccine regimen: Pfizer-BioNTech BNT162b2 mRNA booster vaccine following priming with Novavax NVX-CoV2373
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 1958 - Longitudinal SARS-COV-2 anti-spike antibody response in pregnant people with natural infection and variable vaccine uptake
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET